• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Show Search
Home
EN / FR
  • LinkedIn
  • Twitter
Celyad Oncology

Celyad Oncology

  • About Us
    • Overview
    • Management Team
    • Board Of Directors
    • Scientific Advisory Board
    • Partners
  • Science
    • Overview
    • Approach
    • Technology
      • TIM
      • shRNA
    • Manufacturing
    • Scientific Publications
  • Pipeline
  • Newsroom
    • Press Releases
    • Events
    • Media Center
  • Investors
    • Overview
    • Analyst Coverage
    • Corporate Governance
    • Regulated Information
    • Shareholders Information
    • Shareholders Meeting
  • Contact Us
    • Careers
Home / Investors

Investors

Investors

Corporate Profile

Celyad Oncology is a clinical-stage biotechnology company focused on the discovery and development of CAR T therapies for cancer. The Company is developing a pipeline of allogeneic and autologous CAR T cell therapy candidates for the treatment of both hematological malignancies and solid tumors.

Stock Information
ISIN: BE0974260896-XBRU Updated at
EURONEXT NASDAQ
See Price Chart

Investors Kit

Corporate Presentation

Corporate Fact Sheet

Annual Report 2019

Financial Calendar

March 24, 2021

FY 2020 Financial Results

May 6, 2021

Q1 2021 Financial Results

August 4, 2021

H1 2021 Financial Results

Nov 10, 2021

Q3 2021 Financial Results

Upcoming Events

25

Jan
2021

Keystone eSymposia

See More Events

Latest Financial News

6

Aug
2020

First Half 2020 Financial Report

7

May
2020

First Quarter 2020 Financial Results and Recent Business Highlights

22

Mar
2020

Annual Report 2019

discover all Financial News

Footer

  • About
  • Science
  • Pipeline
  • Newsroom
  • Investors
  • Contact Us
  • LinkedIn
  • Twitter

Copyright © 2020 All Rights Reserved.
Cookie Policy | Privacy Policy | Terms of Use

Our website uses cookies including analytics cookies to help improve it by collecting statistics on how visitors use our website. By clicking on "I accept", you allow us to place these analytics cookies. We also use cookies that are necessary for the good functioning of our website. You can find out more information about the cookies we use by visiting our Cookie Policy. I acceptI refuseCookie Policy